1. Home
  2. TSE vs CLGN Comparison

TSE vs CLGN Comparison

Compare TSE & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinseo PLC

TSE

Trinseo PLC

HOLD

Current Price

$0.38

Market Cap

19.9M

Sector

Industrials

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.69

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSE
CLGN
Founded
2010
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Chemicals
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.9M
18.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TSE
CLGN
Price
$0.38
$0.69
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$1.00
$11.00
AVG Volume (30 Days)
637.6K
114.3K
Earning Date
02-13-2026
03-25-2026
Dividend Yield
5.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,133,800,000.00
$2,475,000.00
Revenue This Year
N/A
$1,596.12
Revenue Next Year
$2.53
$85.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
280.77
52 Week Low
$0.37
$0.59
52 Week High
$5.99
$4.98

Technical Indicators

Market Signals
Indicator
TSE
CLGN
Relative Strength Index (RSI) 32.99 26.39
Support Level $0.42 $0.66
Resistance Level $0.51 $1.99
Average True Range (ATR) 0.04 0.14
MACD 0.00 -0.10
Stochastic Oscillator 0.00 6.52

Price Performance

Historical Comparison
TSE
CLGN

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: